Selective suppression of antigen-specific Th2 cells by continuous micro-dose oral tolerance

X M Wu1, M Nakashima, T Watanabe

  • 1Department of Molecular Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.

Insights

Continuous oral administration of micro-doses of antigen (Ag) tolerized Th2 responses, suppressing Ag-specific IgE production by down-regulating T cell receptor expression, not clonal deletion.

Area of Science:

  • Immunology
  • Allergy Research

Background:

  • Oral administration of antigens can induce immune tolerance.
  • Th2 cell responses are implicated in allergic reactions and IgE production.

Purpose of the Study:

  • To investigate the effect of continuous oral micro-dosing of antigen on Th2 responses and IgE production.
  • To elucidate the mechanisms underlying antigen-specific tolerance induction.

Main Methods:

  • Transgenic mice with ovalbumin (OVA)-specific T cell receptors were fed micro-doses of OVA.
  • Mice were immunized before and after oral treatment.
  • Antigen-specific proliferation, cytokine secretion (IL-4, IL-2, IFN-gamma), antibody production (IgE, IgG1, IgG2a), T cell populations, and antigen-presenting cell markers were analyzed.

Main Results:

  • Oral micro-dosing tolerized Th2 responses, decreasing IL-4 secretion and Ag-specific IgE/IgG1 production, but not Th1 responses (IL-2, IFN-gamma, IgG2a).
  • A decrease in clonotype-specific TCR-high CD4+ T cells was observed, suggesting T cell receptor down-regulation rather than clonal deletion.
  • Reduced expression of B7-2 (CD86) on antigen-presenting cells in the spleen was noted.

Conclusions:

  • Continuous oral micro-dosing of antigen effectively suppresses antigen-specific Th2 responses and IgE production.
  • Tolerance induction is primarily mediated by down-regulation of T cell receptor expression in Th2 cells.
  • This approach offers a potential strategy for managing allergic diseases.